IMC Chicago
INO icon

IMC Chicago’s Inovio Pharmaceuticals INO Stock Holding History

IMC Chicago’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$234K Buy
+212,900
New +$253K ﹤0.01% 5501
2024
Q2 		– Sell
-17,200
Closed -$239K – 2694
2024
Q1 		$239K Buy
+17,200
New +$148K ﹤0.01% 2291
2023
Q1 		– Sell
-19,308
Closed -$361K – 1328
2022
Q4 		$361K Buy
19,308
+7,791
+68% +$177K ﹤0.01% 1181
2022
Q3 		$238K Buy
+11,517
New +$295K ﹤0.01% 1174
2022
Q2 		– Sell
-4,650
Closed -$200K – 1098
2022
Q1 		$200K Sell
4,650
-20,325
-81% -$916K ﹤0.01% 1070
2021
Q4 		$1.5M Sell
24,975
-2,292
-8% -$184K ﹤0.01% 884
2021
Q3 		$2.34M Sell
27,267
-2,541
-9% -$255K ﹤0.01% 808
2021
Q2 		$3.32M Sell
29,808
-12,109
-29% -$1.16M ﹤0.01% 670
2021
Q1 		$4.67M Buy
41,917
+867
+2% +$114K 0.01% 585
2020
Q4 		$4.36M Sell
41,050
-18,075
-31% -$2.41M 0.01% 578
2020
Q3 		$8.23M Buy
59,125
+31,608
+115% +$6.59M 0.01% 338
2020
Q2 		$8.9M Buy
+27,517
New +$4.42M 0.02% 278

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IMC Chicago's INO Position: Q2 2026 in Review

IMC Chicago sold out of Inovio Pharmaceuticals (INO) in Q2 2026, closing a stake of 37,889 shares — an estimated $45K sold.

IMC Chicago first reported a position in INO in Q2 2020 and held it in 3 quarters. The position peaked at $719K in Q2 2020. 102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • IMC Chicago reported no remaining Inovio Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 37,889 Inovio Pharmaceuticals shares in Q2 2026, an estimated $45K.
  • IMC Chicago first reported a position in Inovio Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • IMC Chicago's Inovio Pharmaceuticals position peaked at $719K in Q2 2020.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.